Galileo Life Sciences, Inc. Deferred Tax Assets, Net of Valuation Allowance
Galileo Life Sciences, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2014-12-31, per its 10-Q filed 2016-02-22.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2016-02-22
- 2014-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2014-06-30: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2013-06-30: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2013-03-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2014-12-31 | $0.00 10-Q · filed 2016-02-22 | |
| 2014-06-30 | $0.00 10-Q · filed 2016-02-22 | |
| 2013-06-30 | $0.00 10-K · filed 2014-11-20 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-20 | |
| 2012-12-31 | $0.00 10-Q · filed 2013-02-19 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-30 | |
| 2012-06-30 | $0.00 10-Q · filed 2013-05-20 | $532.44K 10-K · filed 2012-11-14 |
| 2011-06-30 | $0.00 10-K/A · filed 2012-11-21 |